Clinical Trial Update: Open Label Study of Octreotide Implant in Patients With Acromegaly [Phase 2]

View source ↗

Summary

An open-label Phase 2 clinical trial evaluated an octreotide implant for acromegaly. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Octreotide Implant (octreotide)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Acromegaly | Phase 2 | Status: COMPLETED